No Data
Asymchem Laboratories (06821): Some Directors, senior management, and other core technical and Business personnel have cumulatively increased their Shareholding in the company by 0.3984 million shares.
Asymchem Laboratories (06821) issued a notice that some of its Directors, senior management, and Other core technical and Business personnel...
Asymchem Laboratories (002821.SZ) some Directors, senior executives, and key personnel have collectively increased their Shareholding by 0.3984 million shares.
Asymchem Laboratories (002821.SZ) announced that as of the date of this announcement, some of the Directors and senior management...
Asymchem Laboratories (06821): Executive Xiao Yi retires and steps down.
Asymchem Laboratories (06821) announced that the Board of Directors recently received a written application submitted by the company's senior management personnel, Mr. Xiao Yi.
National People's Congress representative, Zhao Jing of Shandong Buchang Pharmaceuticals: "The 'AI+' is reaching a critical point of explosion. It is recommended to utilize AI to empower the inheritance and innovation of Traditional Chinese Medicine | Two
① Zhao Jing, a representative of the National People's Congress and Vice Director of Shandong Buchang Pharmaceuticals, brought the proposal "Utilizing AI to Empower the Inheritance and Innovation of Traditional Chinese Medicine and Build a New Pattern of Development for Traditional Chinese Medicine with 'Asia Vets + Technology'" to this year's Two Sessions, aiming to promote the intelligent upgrade of the Traditional Chinese Medicine industry through AI technology. ② Zhao Jing stated that the development of large models like DeepSeek has indeed pushed the integration of Traditional Chinese Medicine and AI to a critical point of explosion.
The investment secrets in the government work report: Analyzing the collaborative logic of the Global Strategy and policies of Guoshengtang (2273.HK).
The report clearly states to strengthen basic Medical and health services.
Nuvation Bio Enters Supply Agreement With Asymchem For Taletrectinib; 5-Year Initial Term With Automatic 3-Year Renewals
Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Stock Catapults 26% Though Its Price And Business Still Lag The Market
